Change in Directorate

Summary by AI BETAClose X

CT Private Equity Trust PLC announced that Manisha Shukla will join the Board and its committees effective May 29, 2026. Ms. Shukla brings over 20 years of legal advisory experience specializing in investment companies, having previously served as knowledge counsel for funds at Travers Smith LLP and currently as a non-executive director and Chair of the Remuneration Committee for European Opportunities Trust PLC. The Directors anticipate her valuable insights will contribute to the Board's discussions.

Disclaimer*

CT Private Equity Trust PLC
21 April 2026
 

To:                         RNS

From:                    CT Private Equity Trust PLC ("the Company")

Date:                     21 April 2026

 

 

Directorate Change

 

With effect from 29 May 2026, Manisha Shukla will be appointed to the Board and its committees.

 

Manisha is a highly experienced legal adviser with over 20 years of specialisation in investment companies.


She qualified as a solicitor in 2000 and has worked in both private practice and in-house, focusing on a broad range of closed-ended listed investment companies. Most recently, she was the knowledge counsel for funds for Travers Smith LLP. She is currently a non-executive director and Chair of the Remuneration Committee of European Opportunities Trust PLC.

 

The Directors look forward to working with Manisha and to the valuable insights that she will bring to the Board's deliberations.

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 573 8314

Scott McEllen (Company Secretary)

0131 573 8372

hamish.mair@columbiathreadneedle.com  / scott.mcellen@columbiathreadneedle.com



 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings